GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

8600	Companies
140497	Keywords
76472	Articles
75069	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 02/14/2025 at 22:10, 1 month 20 days ago

GENFIT annonce la modification des termes définitifs de la double proposition aux porteurs d’OCEANEs 2025
GENFIT modifie les termes de la proposition de rachat OCEANEs 2025 avec une contrepartie financière pour les porteurs intéressés, conditionnés à l'approbation du Royalty Financing par les porteurs lors de l'AG à venir

Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
PRESS RELEASE

published on 02/14/2025 at 22:10, 1 month 20 days ago

GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces amendment of final terms of dual proposal to 2025 OCEANEs holders, seeking consent for repurchase at EUR 32.75 per bond or a consent fee of EUR 0.90 per bond still outstanding

Repurchase Amendment GENFIT Consent Fee 2025 OCEANEs
BRIEF

published on 02/10/2025 at 07:35, 1 month 24 days ago

GENFIT Proposes Terms for 2025 OCEANEs Bondholders

Royalty Financing GENFIT Bond Repurchase Financial Terms 2025 OCEANEs
BRIEF

published on 02/10/2025 at 07:35, 1 month 24 days ago

GENFIT propose des modalités aux porteurs d'OCEANEs 2025

Rachat D'obligations GENFIT Conditions Financières OCEANE 2025 Financement Par Redevances
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 month 24 days ago

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing

Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 month 24 days ago

GENFIT annonce les termes définitifs de sa double proposition aux porteurs d’OCEANEs 2025
GENFIT annonce les termes de sa double proposition aux porteurs d'OCEANEs 2025, incluant le rachat des obligations ou un paiement financier, liés au royalty financing avec HCRx. Modalités d'approbation et mise en œuvre

Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
BRIEF

published on 02/06/2025 at 22:15, 2 months ago

GENFIT dévoile ses futurs essais cliniques et attentes pour 2025

Biopharmaceutique Essais Cliniques 2025 GENFIT ACLF
BRIEF

published on 02/06/2025 at 22:15, 2 months ago

GENFIT unveils its future clinical trials and expectations for 2025

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF
PRESS RELEASE

published on 02/06/2025 at 22:10, 2 months ago

GENFIT présente le design de ses prochains essais cliniques et rappelle les grandes étapes de développement et données cliniques attendues en 2025
GENFIT présente le design de ses prochains essais cliniques pour son portefeuille ACLF et rappelle les données cliniques attendues en 2025. Le Directeur Général annonce quatre séries de données cliniques attendues d'ici fin 2025

Développement Essais Cliniques GENFIT ACLF Données Cliniques
PRESS RELEASE

published on 02/06/2025 at 22:10, 2 months ago

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
GENFIT outlines anticipated new clinical trial initiations, development milestones, and data readouts in 2025, focusing on Acute on-Chronic Liver Failure (ACLF) pipeline

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF Pipeline

Accesswire

Published on 04/07/2025 at 00:05, 3 hours 18 minutes ago

Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 05:50, 1 day 21 hours ago

Lobe Sciences Provides Corporate Update
Published on 04/05/2025 at 01:50, 2 days 1 hour ago

Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/05/2025 at 01:00, 2 days 2 hours ago

AIML Announces Proposed Private Placement
Published on 04/05/2025 at 00:15, 2 days 3 hours ago

UniDoc Announces LIFE Offering

View all ACCESSWIRE

EQS Group

Published on 04/06/2025 at 18:20, 9 hours 2 minutes ago

EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 12 hours 14 minutes ago

EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 8 hours ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/04/2025 at 18:51, 2 days 8 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/04/2025 at 18:30, 2 days 8 hours ago

Forbo shareholders approved all proposals of the Board of Directors

Les Echos

Published on 04/04/2025 at 19:18, 2 days 8 hours ago

Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 8 hours ago

Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 9 hours ago

Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:17, 2 days 9 hours ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 31 mars et le 3 avril 2025
Published on 04/04/2025 at 18:13, 2 days 9 hours ago

Total number of voting rights and shares making up the share capital at March 31, 2025

View all LES ECHOS COMFI WIRE